|
SBDS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.582600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.482400E-01 |
| Normal-vs-Stage2 |
1.701020E-01 |
| Normal-vs-Stage3 |
3.288300E-02 |
| Normal-vs-Stage4 |
3.220400E-01 |
| Stage1-vs-Stage2 |
4.239600E-01 |
| Stage1-vs-Stage3 |
1.026370E-01 |
| Stage1-vs-Stage4 |
7.507600E-01 |
| Stage2-vs-Stage3 |
7.642000E-01 |
| Stage2-vs-Stage4 |
7.442800E-01 |
| Stage3-vs-Stage4 |
5.200600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.329600E-01 |
| Normal-vs-AfricanAmerican |
7.263800E-01 |
| Normal-vs-Asian |
9.136400E-01 |
| Caucasian-vs-AfricanAmerican |
6.979800E-01 |
| Caucasian-vs-Asian |
9.028400E-01 |
| AfricanAmerican-vs-Asian |
9.914400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.184400E-01 |
| Normal-vs-Female |
4.419400E-01 |
| Male-vs-Female |
8.481200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.809400E-01 |
| Normal-vs-Extreme_Weight |
8.239200E-01 |
| Normal-vs-Obese |
9.853000E-01 |
| Normal-vs-Extreme_Obese |
2.463000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.101400E-01 |
| Normal_Weight-vs-Obese |
2.022200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.016600E-01 |
| Extreme_Weight-vs-Obese |
8.538000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.401400E-01 |
| Obese-vs-Extreme_Obese |
2.010600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.951000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.473800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.708420E-02 |
| Normal-vs-Age(81-100Yrs) |
9.831600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.786400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.711600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.029200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.564300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.443200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.075200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.989620E-01 |
| Normal-VS-Type2 PRCC |
2.376300E-03 |
| Normal-VS-KIRP CIMP |
1.035610E-01 |
| Normal-VS-Unclassified PRCC |
6.865600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.03390000000003E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.004200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.397200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.141000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.582000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.964000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.101100E-03 |
| Normal-vs-N1 |
3.795900E-02 |
| Normal-vs-N2 |
1.711830E-01 |
| N0-vs-N1 |
5.474000E-01 |
| N0-vs-N2 |
8.340800E-01 |
| N1-vs-N2 |
9.341400E-01 |
|
|
